• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nls Pharmaceutics Ltd (NQ: NLSP )

    0.2040 +0.0130 (+6.81%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,561,848
    Open 0.1910
    Bid (Size) 0.1943 (40)
    Ask (Size) 0.2050 (300)
    Prev. Close 0.1910
    Today's Range 0.1810 - 0.2093
    52wk Range 0.1112 - 1.205
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    NLS Pharmaceutics Announces Registered Direct Offering
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
    Via ACCESSWIRE

    Performance

    YTD
    -65.30%
    -65.30%
    1 Month
    +14.35%
    +14.35%
    3 Month
    +63.20%
    +63.20%
    6 Month
    -57.05%
    -57.05%
    1 Year
    -73.66%
    -73.66%

    More News

    Read More
    Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
    Via ACCESSWIRE
    PLTR Stock: Palantir Bags New Partnership With ARPA-H for AI/ML
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Is NLS Pharmaceutics (NLSP) Stock Up 163% Today?
    Via InvestorPlace
    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Dow Edges Lower; US Current Account Deficit Widens In Q1
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?
    Via InvestorPlace
    Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    US Stocks Mixed; Retail Sales Increase 0.1% In May
    Via Benzinga
    Why Is Quantum (QMCO) Stock Down 32% Today?
    Via InvestorPlace
    Why Is Aerwins Technologies (AWIN) Stock Down 54% Today?
    Via InvestorPlace
    Why Is Actelis Networks (ASNS) Stock Up 144% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)
    Via ACCESSWIRE
    NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
    Via ACCESSWIRE
    NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
    Via ACCESSWIRE
    NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
    Via ACCESSWIRE
    NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
    Via ACCESSWIRE
    NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.